Alem­bic Pharma

BioSpectrum (India) - - COVER STORY -

Head­quar­tered in Vado­dara, Alem­bic has 4 stateof-the-art man­u­fac­tur­ing fa­cil­i­ties in Gu­jarat and Sikkim as well as three R&D cen­tres in Vado­dara, Hyderabad and USA. Hav­ing es­tab­lished a front-end setup in the US in 2015, the com­pany is now ea­ger to grow its Amer­i­can foot­print. In FY2018, Alem­bic’s re­search and de­vel­op­ment spend was Rs 4.8 bil­lion which is equiv­a­lent to 13 per cent of sales. Of this long-term ex­pen­di­ture 90 per cent is fo­cused on build­ing ca­pa­bil­i­ties for the US mar­ket.

Key High­lights – FY2018

Launched 13 new prod­ucts and 10 more launches

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.